AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-18.28%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.29B
AUM Growth
+$2.29B
(-27%)
Cap. Flow
-$77.6M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
70.19%
Holding
122
New
8
Increased
14
Reduced
14
Closed
21
Top Buys
| 1 |
Neumora Therapeutics
NMRA
|
$39.5M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$23.4M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$12.3M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$11.8M |
| 5 |
Sagimet Biosciences
SGMT
|
$8.14M |
Top Sells
| 1 |
Krystal Biotech
KRYS
|
$41.1M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$23.5M |
| 3 |
MoonLake Immunotherapeutics
MLTX
|
$20.4M |
| 4 |
Relay Therapeutics
RLAY
|
$15.2M |
| 5 |
Protagonist Therapeutics
PTGX
|
$13.8M |
Sector Composition
| 1 | Healthcare | 55.33% |
| 2 | Consumer Discretionary | 43.57% |
| 3 | Technology | 0.62% |
| 4 | Communication Services | 0.2% |
| 5 | Real Estate | 0.19% |
